Progesterone supplements do not improve outcomes for women with recurrent miscarriages

The findings from a five-year trial funded by the HTA programme has published in The New England Journal of Medicine. The progesterone in miscarriage treatment (PROMISE) trial conducted in 45 hospitals in the UK and the Netherlands, involved 826 women with unexplained recurrent miscarriage. The findings showed that those who received progesterone treatment in early...
Source: NIHR Evaluation, Trials and Studies News - Category: American Health Source Type: news